1-2 of 2
Mary Campbell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations
Alex F. Herrera, Alison J. Moskowitz, Nancy L. Bartlett, Julie M. Vose, Radhakrishnan Ramchandren, Tatyana A. Feldman, Ann S. LaCasce, Stephen M. Ansell, Craig H. Moskowitz, Keenan Fenton, Carol Anne Ogden, David Taft, Qu Zhang, Kazunobu Kato, Mary Campbell, Ranjana H. Advani
Journal: Blood
Blood (2018) 131 (11): 1183–1194.
https://doi.org/10.1182/blood-2017-10-811224
Published: 2018
Includes: Supplemental data
Journal Articles

Results from a Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma

Alex F. Herrera, MD, Alison J. Moskowitz, MD, Nancy L. Bartlett, MD, Julie M Vose, MD, Radhakrishnan Ramchandren, MD, Tatyana A Feldman, MD, Ann S LaCasce, MD MSc, Stephen M Ansell, MD PhD, Craig H. Moskowitz, MD, Keenan Fenton, Carol Anne Ogden, David Taft, Qu Zhang, Kazunobu Kato, Mary Campbell, MD, Ranjana H. Advani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 649.
https://doi.org/10.1182/blood.V130.Suppl_1.649.649
Published: 2017